Følg
Ulrik Lassen, Professor, MD, PH.D.
Ulrik Lassen, Professor, MD, PH.D.
Phase 1 Unit, Department of Oncology
Verificeret mail på regionh.dk - Startside
Titel
Citeret af
Citeret af
År
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
A Drilon, TW Laetsch, S Kummar, SG DuBois, UN Lassen, GD Demetri, ...
New England Journal of Medicine 378 (8), 731-739, 2018
24492018
Targeting CD38 with daratumumab monotherapy in multiple myeloma
HM Lokhorst, T Plesner, JP Laubach, H Nahi, P Gimsing, M Hansson, ...
New England Journal of Medicine 373 (13), 1207-1219, 2015
12672015
Actively personalized vaccination trial for newly diagnosed glioblastoma
N Hilf, S Kuttruff-Coqui, K Frenzel, V Bukur, S Stevanović, ...
Nature 565 (7738), 240-245, 2019
7322019
Preoperative staging of lung cancer with combined PET–CT
B Fischer, U Lassen, J Mortensen, S Larsen, A Loft, A Bertelsen, J Ravn, ...
New England Journal of Medicine 361 (1), 32-39, 2009
6872009
Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
V Subbiah, U Lassen, E Élez, A Italiano, G Curigliano, M Javle, ...
The Lancet Oncology 21 (9), 1234-1243, 2020
3672020
Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.
U Lassen, K Osterlind, M Hansen, P Dombernowsky, B Bergman, ...
Journal of clinical oncology 13 (5), 1215-1220, 1995
3471995
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial
B Hasselbalch, U Lassen, S Hansen, M Holmberg, M Sørensen, ...
Neuro-oncology 12 (5), 508-516, 2010
2682010
First-in-class, first-in-human phase I study of selinexor, a selective inhibitor of nuclear export, in patients with advanced solid tumors
ARA Razak, M Mau-Soerensen, NY Gabrail, JF Gerecitano, AF Shields, ...
Journal of Clinical Oncology 34 (34), 4142, 2016
2192016
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis
BM Fischer, J Mortensen, SW Langer, A Loft, AK Berthelsen, BL Petersen, ...
Annals of Oncology 18 (2), 338-345, 2007
2002007
18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT)
U Lassen, G Daugaard, A Eigtved, K Damgaard, L Friberg
European Journal of Cancer 35 (7), 1076-1082, 1999
1991999
Hallmarks of glioblastoma: a systematic review
DS Nørøxe, HS Poulsen, U Lassen
ESMO open 1 (6), e000144, 2016
1912016
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized …
A Omuro, AA Brandes, AF Carpentier, A Idbaih, DA Reardon, ...
Neuro-oncology 25 (1), 123-134, 2023
1842023
Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction
G Daugaard, U Lassen, P Bie, EB Pedersen, KT Jensen, U Abildgaard, ...
European journal of heart failure 7 (1), 87-93, 2005
1692005
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial
JS De Bono, N Concin, DS Hong, FC Thistlethwaite, JP Machiels, ...
The lancet oncology 20 (3), 383-393, 2019
1522019
Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma
T Plesner, HT Arkenau, P Gimsing, J Krejcik, C Lemech, MC Minnema, ...
Blood, The Journal of the American Society of Hematology 128 (14), 1821-1828, 2016
1382016
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer
K Jacobsen, J Bertran-Alamillo, MA Molina, C Teixidó, N Karachaliou, ...
Nature communications 8 (1), 410, 2017
1362017
Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours
U Lassen, G Daugaard, A Eigtved, L Højgaard, K Damgaard, M Rørth
European journal of nuclear medicine and molecular imaging 30, 396-402, 2003
1352003
Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours
HS Poulsen, K Grunnet, M Sorensen, P Olsen, B Hasselbalch, ...
Acta Oncologica 48 (1), 52-58, 2009
1302009
First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer
C Massard, A Azaro, JC Soria, U Lassen, C Le Tourneau, D Sarker, ...
Annals of Oncology 29 (9), 1911-1917, 2018
1202018
Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced …
H Borghaei, K Alpaugh, G Hedlund, G Forsberg, C Langer, A Rogatko, ...
Journal of Clinical Oncology 27 (25), 4116, 2009
1132009
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20